Cisplatin and Etoposide Versus Carboplatin and Paclitaxel With Concurrent Radiotherapy for Stage III Non–Small-Cell Lung Cancer: An Analysis of Veterans Health Administration Data

PURPOSE: The optimal chemotherapy regimen to use with radiotherapy in stage III non–small-cell lung cancer is unknown. Here, we compare the outcome of patents treated within the Veterans Health Administration with either etoposide-cisplatin (EP) or carboplatin-paclitaxel (CP). METHODS: We identified...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Autores principales: Santana-Davila, Rafael, Devisetty, Kiran, Szabo, Aniko, Sparapani, Rodney, Arce-Lara, Carlos, Gore, Elizabeth M., Moran, Amy, Williams, Christina D., Kelley, Michael J., Whittle, Jeffrey
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2015
Materias:
ORIGINAL REPORTS
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4322259/
https://ncbi.nlm.nih.gov/pubmed/25422491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.56.2587
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares